JAK2 and acquired polycythemia vera: Of note, only 10–17% of the UKBB-PV cohort had a JAK2V617F mutation (n = 1 or ≥2 reads, respectively; Supplementary Table 1), although mutated JAK2 is expected to be found in >99% of PV cases.